MASLD significantly increases the risk of kidney stones, with an odds ratio of 3.38, compared to 1.96 for MASH. The study used data from over 140 million hospitalizations, making it one of the largest ...
The AI-powered platform elevates cardiometabolic care by extending its best-in-class weight management support to CKD and MASH. Welldoc®, a leading AI-powered health tech company pioneering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback